Goldstone Resources (LON: GRL) is raising £2m at 1p/share, which was more than double the share price ahead of the announcement. The cash will fund exploration at the Homase mine in Ghana to expand the JORC resource and to evaluate other gold projects, including one in Sierra Leone. Asian Investment Management is converting £1.45m of interest on its gold loan to shares at a conversion price base on a gold price of $4,250/ounce, taking its shareholding to 29.9%. This leaves 250 ounces of interest and the principal gold loan of 1,871.31 ounces. Directors are also taking 50% of fees owed in shares at 1p/share. The share price jumped 47.4% to 0.7p.
Sovereign Metals (LON: SVML) says that there are exceptionally high levels of rare earth elements Dysprosium-Terbium, used in magnets, and Yttrium, used for aerospace, in Monazite from the Kasiya rutile tailings in Malawi. Monazite can generate another stream of revenues. These are by-products of the rutile processing, which is the primary focus. The share price increased 33.8% to 40.8p.
Pulsar Helium (LON: PLSR) has issued a further 145,434 consideration shares to Aquis-quoted Oscillate (LON: SRVL) as part of the deal to acquire Quantum Hydrogen. This takes the stake to 80% with an option to the acquire rest for $400,000 in shares issued in five equal instalments. 2D seismic surveying has started at the Topaz helium project in Minnesota and should be completed in March. The share price gained 22.6% to 89.5p.
Microbiome-based products developer OptiBiotix Health (LON: OPTI) has received a 24 tonnes order of appetite reduction ingredient SlimBiome from Meelung Trading in Taiwan. There will be four deliveries this year at three month intervals. This will enable an increase in the scale of production enabling greater efficiency. The share price recovered 17.2% to 7.5p.
Oil condition monitoring equipment supplier Tan Delta Systems (LON: TAND) generated revenues of £1.2m in 2025, which is one-fifth higher than anticipated. There are customers undertaking trials of equipment that should be near to making purchasing decisions. Net cash was £1.4m at the end of 2025, but a fundraising may be required depending on the rate of new orders. The share price improved 13.9% to 37p.
FALLERS
Shares in Indus Gas (LON: INDI) slumped by one-third to 1.335p ahead of leaving AIM on 23 January. JP Jenkins will provide a matched bargains facility.
Eqtec (LON: EQT) has published a circular for a general meeting on 12 February to gain shareholder approval for broadening its strategy to gain exposure to critical and precious metals, while continuing with the core waste to energy technology business. This fits with the energy transition sector strategy. The share price fell 15.4% to 0.11p, but it is still much higher than prior to the announcement of the strategy change.
Firering Strategic Minerals (LON: FRG) intends to exercise the next tranche of the Limeco Resources option, which will take its shareholding to 36.2%. Firering Strategic Minerals boss Yuval Cohen will step down and concentrate on his role as chief executive of lime producer Limeco Resources in Zambia. A new kiln will increase production capacity. Youval Rasin will be interim chief executive of Firering Strategic Minerals. The share price declined 11.1% to 1.2p.
Iron deficiency treatment developer Shield Therapeutics (LON: STX) expects to achieve an operating profit in 2026, having generated $1m in cash from operations in the fourth quarter of 2025. In 2025, revenues rose from $32m to $50m with $46m coming from iron deficiency treatment ACCRUFeR through a combination of higher prices and more prescriptions. There were 61,000 prescriptions in the fourth quarter, up from 41,000 one year earlier. Cash was $11.6m at the end of 2025, although there is still net debt. The share price dipped 6.67% to 10.5p.

